Corporate calendar for Crinetics Pharmaceuticals, Inc. (CRNX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | $-0.16 | $7M |
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $-0.01 | $11M |
Price
| Price | $84.95 |
| Market Cap | $9.0B |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 13 |
| Hold | 8 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 21 |
| Avg rating (1-5) | 0.62 |
Related companies: ACAD · AKRO · DYN · IMVT · KYMR · NAMS · PRAX
Explore sector: Healthcare · Biotechnology
More sections of CRNX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks